Hong Kong stocks of innovative drug concept stocks fell collectively, Zaiding Pharmaceutical (09688.HK) fell more than 11%, Hengrui Pharmaceutical (01276.HK), Goree Pharmaceutical (01672.HK), Genting Xinyao (01952.HK) fell more than 5%, WuXi AppTec (02359.HK) fell more than 4%, Cinda Biological (01801.HK), WuXi Ming United (02268.HK), Hansen Pharmaceutical (03692.HK) fell more than 3%.
港股创新药概念股集体下跌,再鼎医药(09688.HK)跌超11%,恒瑞医药(01276.HK)、歌礼制药(01672.HK)、云顶新耀(01952.HK)跌超5%,药明康德(02359.HK)跌超4%,信达生物(01801.HK)、药明合联(02268.HK)、翰森制药(03692.HK)跌超3%。
Hong Kong stocks closed, the Hang Seng Index closed up 0.68%, the Branch Index closed up 0.73%, the biotechnology sector rose sharply, Junshi Biosciences (01877.HK) rose 33.75%, Ge Li Pharmaceutical (01672.HK) rose 15.4%.
Hong Kong stocks biotechnology sector rose, Geli Pharmaceutical (01672.HK) rose more than 15%, Yasheng Pharmaceutical (06855.HK) rose more than 9%, Jiahe Bio (06998.HK), Fuhong Hanlin (02696.HK) rose more than 8%, Kang Xinuo Bio (06185.HK), Zaiding Pharmaceutical (09688.HK) rose more than 5%.
Hong Kong biotechnology stocks continued to rise in the afternoon, Cornerstone Pharmaceutical (02616.HK) rose more than 25%, Kangxino Biological (06185.HK) rose more than 15%, Rongchang Biological (09995.HK), WuXi AppTec (02359.HK), Goree Pharmaceutical (01672.HK) rose more than 10%, Junshi Biosciences (01877.HK) rose more than 7%, WuXi Propaganda (02126.HK) rose more than 6%.